Suchergebnisse - "Knopinska-Posluszny, Wanda"

PubPharm (68)

1

Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia : the PETHEMA-PALG experience

enthalten in: Annals of hematology | 2024

von Sobas, M. | Knopinska-Posluszny, W. | Piątkowska-Jakubas, B. | +30

2

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients With Multiple Myeloma Over 75 Years of Age

enthalten in: Preprints.org | 2023

von Tyczyńska, A. | Krzemek, M. | Cortez, A. | +22

3

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age

enthalten in: Cancers | 2023

von Tyczyńska, A. | Krzempek, M. | Cortez, A. | +22

4

Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma

enthalten in: Journal of cancer research and clinical oncology | 2023

von Topp, M. | Eradat, H. | Florschütz, A. | +12

5

A survey across orbital lymphoma in Poland : Multicenter retrospective study of polish lymphoma research group (PLRG)

enthalten in: Cancer medicine | 2023

von Kalicińska, E. | Giza, A. | Zaucha, J. | +12

6

A survey across orbital lymphoma in Poland : Multicenter retrospective study of polish lymphoma research group ( PLRG)

enthalten in: Cancer Medicine | 2023

von Kalicińska, E. | Giza, A. | Zaucha, J. | +12

7

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma

enthalten in: British journal of haematology | 2022

von Paszkiewicz-Kozik, E. | Michalski, W. | Taszner, M. | +25

8

Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma

enthalten in: Journal of cancer research and clinical oncology | 2022

von Topp, M. | Eradat, H. | Florschütz, A. | +12

9

Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma

enthalten in: Journal of cancer research and clinical oncology | 2022

von Topp, M. | Eradat, H. | Florschütz, A. | +12

10

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation‐ineligible relapsed and refractory diffuse large B‐cell lymphoma

enthalten in: British Journal of Haematology | 2022

von Paszkiewicz‐Kozik, E. | Michalski, W. | Taszner, M. | +25

1
2
3
4
5
6
7
Nächster »
[7]